The mechanism underlying the anticancer effect of cucurbitacin B is not clear; however, several studies have shown that cucurbitacin B inhibits the proliferation of, and induces apoptosis in, human cancer cells via STAT3 pathway inhibition and increased intracellular reactive oxygen species (ROS) [29,36,37,38,39,40]. Here, STAT3 is linked to cancer.